Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

M. Dimachkie · SciRah

Researcher profile · Semantic Scholar

M. Dimachkie

Share profile

M. Dimachkie — researcher profile on SciRah

h-index: 46
Works: 317
Citations: 8,411

Most-cited papers

Trial of Intravenous Immune Globulin in Dermatomyositis.
R. Aggarwal, C. Charles-Schoeman, J. Schessl, Z. Bata-Csörgő +26 more
2022New England Journal of Medicine164 citations Open access
Semantic Scholar
International Guideline for Idiopathic Inflammatory Myopathy-Associated Cancer Screening
A. Oldroyd, J. Callen, H. Chinoy, Lorinda S. Chung +75 more
2023Nature Reviews Rheumatology141 citations Open access
Semantic Scholar
Zilucoplan in immune-mediated necrotising myopathy: a phase 2, randomised, double-blind, placebo-controlled, multicentre trial
A. Mammen, A. Amato, M. Dimachkie, H. Chinoy +12 more
2023The Lancet Rheumatology52 citations Open access
Semantic Scholar
Efficacy and Safety of Avalglucosidase Alfa in Patients With Late-Onset Pompe Disease After 97 Weeks
P. Kishnani, J. Diaz-Manera, A. Toscano, P. Clemens +23 more
2023JAMA Neurology41 citations Open access
Semantic Scholar
Imaging biomarkers in the idiopathic inflammatory myopathies
Adeel S. Zubair, Sharfaraz Salam, M. Dimachkie, P. Machado +1 more
2023Frontiers in Neurology31 citations Open access
Semantic Scholar
BCMA-directed mRNA CAR T cell therapy for myasthenia gravis: a randomized, double-blind, placebo-controlled phase 2b trial
T. Vu, H. Durmuş, M. Rivner, S. Shroff +26 more
2026Nature Medicine30 citations Open access
Semantic Scholar
Randomized Trial of Tocilizumab in the Treatment of Refractory Adult Polymyositis and Dermatomyositis
C. Oddis, H. Rockette, Lei Zhu, D. Koontz +10 more
2022ACR Open Rheumatology30 citations Open access
Semantic Scholar
Safety and efficacy of arimoclomol for inclusion body myositis: a multicentre, randomised, double-blind, placebo-controlled trial.
P. Machado, Michael P. McDermott, T. Blaettler, Claus Sundgreen +20 more
2023Lancet Neurology28 citations Open access
Semantic Scholar
Diagnostic and prognostic value of anti-cN1A antibodies in inclusion body myositis.
Sharfaraz Salam, M. Dimachkie, M. Hanna, P. Machado
2022Clinical and Experimental Rheumatology26 citations Open access
Semantic Scholar
Addressing Outcome Measure Variability in Myasthenia Gravis Clinical Trials
J. Guptill, M. Benatar, V. Granit, A. A. Habib +8 more
2023Neurology22 citations Open access
Semantic Scholar
Randomized Double-Blind Placebo-Controlled Trial of the Corticosteroid-Sparing Effects of Immunoglobulin in Myasthenia Gravis
V. Bril, A. Szczudlik, A. Vaitkus, C. Rózsa +21 more
2022Neurology21 citations Open access
Semantic Scholar
Safety and tolerability of intravenous immunoglobulin in patients with active dermatomyositis: results from the randomised, placebo-controlled ProDERM study
R. Aggarwal, J. Schessl, C. Charles-Schoeman, Z. Bata-Csörgő +9 more
2024Arthritis Research & Therapy20 citations Open access
Semantic Scholar
Immune checkpoint inhibitor-related myositis: from pathophysiology to treatment.
Chandrasekhar Sundarrajan, Salman F. Bhai, M. Dimachkie
2022Clinical and Experimental Rheumatology19 citations Open access
Semantic Scholar
Standardization of Myasthenia Gravis Outcome Measures in Clinical Practice: A Report of the MGFA Task Force
Katherine Ruzhansky, Yue-Bing Li, Gil I. Wolfe, S. Muppidi +6 more
2025Muscle and Nerve16 citations Open access
Semantic Scholar
Effect of avalglucosidase alfa on disease-specific and general patient-reported outcomes in treatment-naïve adults with late-onset Pompe disease compared with alglucosidase alfa: Meaningful change analyses from the Phase 3 COMET trial.
Antonio Toscano, L. Pollissard, J. Msihid, N. V. D. van der Beek +9 more
2023Molecular Genetics and Metabolism16 citations Open access
Semantic Scholar
Measuring change in inclusion body myositis: clinical assessments versus imaging.
L. Alfano, Kendrea L. (Focht) Garand, G. Malandraki, Sharfaraz Salam +2 more
2022Clinical and Experimental Rheumatology16 citations Open access
Semantic Scholar
Performance of the 2017 EULAR/ACR Classification Criteria for Adult and Juvenile Idiopathic Inflammatory Myopathies and their Major Subgroups: A Scoping Review
D. Saygin, S. Glaubitz, Rachel Zeng, Matteo Bottai +15 more
2024Clinical and Experimental Rheumatology15 citations Open access
Semantic Scholar
Efficacy and safety of avalglucosidase alfa in patients with late-onset Pompe disease after 145 weeks of treatment during the COMET trial
Priya S. Kishnani, J. Diaz-Manera, S. Illarioshkin, A. T. van der Ploeg +21 more
2025Journal of Neurology10 citations Open access
Semantic Scholar
Switching treatment to cipaglucosidase alfa plus miglustat positively affects patient-reported outcome measures in patients with late-onset Pompe disease
Priya S. Kishnani, Barry J. Byrne, K. Claeys, J. Diaz-Manera +73 more
2024Journal of Patient-Reported Outcomes10 citations Open access
Semantic Scholar
Optimism in inclusion body myositis: a double-blind randomised controlled phase III trial investigating the effect of sirolimus on disease progression in patients with IBM as measured by the IBM Functional Rating Scale.
U. Badrising, R. Henderson, Stephen Reddel, Alastair Corbett +33 more
2025Clinical and Experimental Rheumatology9 citations Open access
Semantic Scholar
Electrodiagnostic subtyping in Guillain–Barré syndrome patients in the International Guillain–Barré Outcome Study
S. Arends, J. Drenthen, L. D. de Koning, P. Van den Bergh +35 more
2024European Journal of Neurology8 citations Open access
Semantic Scholar
Resistance exercise in early-stage ALS patients, ALSFRS-R, Sickness Impact Profile ALS-19, and muscle transcriptome: a pilot study
O. Jawdat, Jason L. Rucker, Tomoki Nakano, Kotaro Takeno +13 more
2024Scientific Reports8 citations Open access
Semantic Scholar
A 40‐week phase 2B randomized, multicenter, double‐blind, placebo‐controlled study evaluating the safety and efficacy of memantine in amyotrophic lateral sclerosis
Salman F. Bhai, Todd D. Levine, D. Moore, R. Bowser +22 more
2024Muscle and Nerve8 citations Open access
Semantic Scholar
Study to Assess Content Validity and Interrater and Intrarater Reliability of the Inclusion Body Myositis Functional Rating Scale.
T. Symonds, J. Randall, Lucy Lloyd-Price, S. Hudgens +3 more
2023Neurology Clinical Practice8 citations Open access
Semantic Scholar
Predictors of response to intravenous immunoglobulin in patients with dermatomyositis: the ProDERM study
C. Charles-Schoeman, J. Schessl, Z. Bata-Csörgő, M. Dimachkie +8 more
2025Rheumatology7 citations Open access
Semantic Scholar
Switching Enzyme Replacement Therapy for Late‐Onset Pompe Disease From Alglucosidase Alfa to Cipaglucosidase Alfa Plus Miglustat: Post Hoc Effect Size Analysis of PROPEL
Hani Kushlaf, J. Díaz-Manera, D. Bratkovic, Barry J. Byrne +13 more
2025Muscle and Nerve7 citations Open access
Semantic Scholar
Phenotypic spectrum of inclusion body myositis.
Bhaskar Roy, M. Dimachkie, E. Naddaf
2024Clinical and Experimental Rheumatology7 citations Open access
Semantic Scholar
Phase 2 trial in acetylcholine receptor antibody‐positive myasthenia gravis of transition from intravenous to subcutaneous immunoglobulin: The MGSCIg study
M. Pasnoor, V. Bril, T. Levine, Jaya R. Trivedi +11 more
2023European Journal of Neurology7 citations
Semantic Scholar
Measurement Properties of 2 Novel PROs, the Pompe Disease Symptom Scale and Pompe Disease Impact Scale, in the COMET Study
M. Dimachkie, P. Kishnani, C. Ivanescu, G. Flore +8 more
2023Neurology Clinical Practice7 citations Open access
Semantic Scholar
Consensus nomenclature and abbreviation for anti-synthetase syndrome: an IMACS project.
Anushka Aggarwal, Tanya Chandra, S. Keret, J. Pauling +32 more
2025Rheumatology6 citations Open access
Semantic Scholar
Measurement properties of the Inclusion Body Myositis Functional Rating Scale
Sharfaraz Salam, T. Symonds, H. Doll, Sam Rousell +9 more
2024Journal of Neurology Neurosurgery & Psychiatry6 citations
Semantic Scholar
Applying the win ratio method in clinical trials of orphan drugs: an analysis of data from the COMET trial of avalglucosidase alfa in patients with late-onset Pompe disease
Matthias Boentert, K. I. Berger, Jordi Díaz-Manera, M. Dimachkie +6 more
2024Orphanet Journal of Rare Diseases6 citations Open access
Semantic Scholar
CIDP prognosis in patients with IVIG treatment‐related fluctuations
Melissa Cook, M. Pasnoor, S. Ajroud-Driss, T. Brannagan +2 more
2022Muscle and Nerve6 citations Open access
Semantic Scholar
Non-Dystrophic Myotonia: 2-year clinical and patient reported outcomes
Timothy R. Fullam, Swathy Chandrashekhar, C. Farmakidis, O. Jawdat +3 more
2022Muscle and Nerve6 citations Open access
Semantic Scholar
A protocol for scoping reviews on the role of whole-body and dedicated body-part magnetic resonance imaging for assessment of adult and juvenile idiopathic inflammatory myopathies
M. Essouma, D. B. de Araújo, J. Day, E. Conticini +32 more
2024Rheumatology International5 citations Open access
Semantic Scholar
Efficacy and safety of avalglucosidase alfa in participants with late-onset Pompe disease after 145 weeks of treatment during the COMET trial
P. Kishnani, J. Diaz-Manera, H. Kushlaf, Shafeeq Ladha +20 more
2023Molecular Genetics and Metabolism5 citations
Semantic Scholar
Quantitative muscle magnetic resonance imaging as a biomarker for inclusion body myositis in clinical trials: exploring the in vivo effects of arimoclomol.
Sharfaraz Salam, J. Morrow, Michael P. McDermott, N. Zafeiropoulos +8 more
2025Clinical and Experimental Rheumatology4 citations
Semantic Scholar
Collaborative research in myositis-related disorders: MIHRA, a global shared community model.
L. Saketkoo, J. Paik, H. Alexanderson, M. Dimachkie +27 more
2024Clinical and Experimental Rheumatology4 citations Open access
Semantic Scholar
Imaging swallowing function and the mechanisms driving dysphagia in inclusion body myositis.
Sharfaraz Salam, J. Allen, M. Dimachkie, Michael G. Hanna +1 more
2023Clinical and Experimental Rheumatology4 citations Open access
Semantic Scholar
Imaging beyond muscle magnetic resonance imaging in inclusion body myositis.
N. Goyal, T. Mozaffar, M. Dimachkie
2022Clinical and Experimental Rheumatology4 citations Open access
Semantic Scholar
Efficacy of Intravenous Immunoglobulin for Systemic Manifestations of Dermatomyositis Beyond Muscular and Cutaneous: Sub-analysis of the ProDERM Study
R. Aggarwal, J. Schessl, Z. Bata-Csörgő, M. Dimachkie +8 more
2025Rheumatology and Therapy3 citations Open access
Semantic Scholar
Pattern Recognition of Neuropathy and Neuronopathy
R. Barohn, M. Dimachkie, Todd D. Levine, D. Saperstein +1 more
2024RRNMF Neuromuscular Journal3 citations Open access
Semantic Scholar
Update on the evaluation and management of dysphagia in sporadic inclusion body myositis
Kendrea L. (Focht) Garand, Georgia A Malandraki, M. Dimachkie
2023Current Opinion in Otolaryngology & Head and Neck Surgery3 citations
Semantic Scholar
Post-hoc Nonparametric Analysis of Forced Vital Capacity in the COMET Trial Demonstrates Superiority of Avalglucosidase Alfa vs Alglucosidase Alfa
Matthias Boentert, E. S. Campana, S. Attarian, J. Diaz-Manera +6 more
2023Journal of Neuromuscular Diseases3 citations Open access
Semantic Scholar
Conducting a bayesian multi-armed trial with response adaptive randomization for comparative effectiveness of medications for CSPN
Alexandra R. Brown, Byron J. Gajewski, D. Mudaranthakam, M. Pasnoor +5 more
2023Contemporary Clinical Trials Communications3 citations Open access
Semantic Scholar
Factors associated with the severity of COVID‐19 outcomes in people with neuromuscular diseases: Data from the International Neuromuscular COVID‐19 Registry
C. Pizzamiglio, R. Pitceathly, M. Lunn, S. Brady +16 more
2022European Journal of Neurology3 citations Open access
Semantic Scholar
Guillain-Barré Syndrome and Variants.
Long Davalos, J. Kissel, R. Barohn, M. Dimachkie
2025Neurologic clinics2 citations
Semantic Scholar
Imaging evaluation of the upper limbs in inclusion body myositis: an unmet need.
Sharfaraz Salam, J. Morrow, Sachit Shah, Michael G. Hanna +2 more
2025Clinical and Experimental Rheumatology2 citations
Semantic Scholar
NEO1/NEO-EXT studies: Long-term muscle quantitative magnetic resonance imaging and functional efficacy in adults with late-onset Pompe disease (LOPD) on avalglucosidase alfa treatment
B. Byrne, P. Carlier, J. Vissing, M. Dimachkie +14 more
2024Molecular Genetics and Metabolism2 citations
Semantic Scholar
Ratio of Distal to Proximal Epidermal Nerve Fiber Density in Small Fiber Neuropathy (P1-11.006)
Georgette Dib, Matthew Varon, O. Jawdat, C. Farmakidis +4 more
2024Neurology2 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

T. Mozaffar×10
Invite
T. Mozaffar — researcher profile on SciRah
R. Barohn×10
Invite
R. Barohn — researcher profile on SciRah
C. Oddis×8
Invite
C. Oddis — researcher profile on SciRah
B. Schoser×8
Invite
B. Schoser — researcher profile on SciRah

×7

Invite

N. Thibault — researcher profile on SciRah

Sharfaraz Salam×7

Invite

Sharfaraz Salam — researcher profile on SciRah

Invite

M. Pasnoor — researcher profile on SciRah

J. Vencovský×6

Invite

J. Vencovský — researcher profile on SciRah

J. Diaz-Manera×6

Invite

J. Diaz-Manera — researcher profile on SciRah

Invite

Z. Griger — researcher profile on SciRah

Invite

L. Herbelin — researcher profile on SciRah

Michael G. Hanna×5

Invite

Michael G. Hanna — researcher profile on SciRah